TRV GP V, LLC

CIK 0001990717 · BOSTON, MA · Quarter end: 2026-06-30 · Filed on: 2026-08-10 · Open the SEC source

TRV GP V, LLC reported 3 positions worth $498.2M as of June 30, 2026 (13F filed August 10, 2026). Largest holding: RAPP (52.5%).

Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$498.2M
2026 Q2
Positions
3
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
100.0%
Est. Net Flow (Q)
2026 Q2
3 positions shown
#SymbolCompanyTypeValue% Port.Shares1YYTD
1RAPPRAPPORT THERAPEUTICS, INC.SH$261.7M52.53%6,280,525
2SEPNSEPTERNA, INC.SH$208.2M41.78%6,215,591
3MAZEMAZE THERAPEUTICS, INC.SH$28.4M5.69%950,800

Read the 2026-Q2 quarterly report · 13F Filing Calendar

Frequently Asked Questions

What stocks does TRV GP V, LLC hold as of Q2 2026?

TRV GP V, LLC reported 3 positions worth $498.2M in its Q2 2026 13F filing. Largest positions: RAPP (52.5%), SEPN (41.8%) and MAZE (5.7%).

What did TRV GP V, LLC buy in Q2 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did TRV GP V, LLC sell in Q2 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.